Bloomage BioTechnology Corporation Limited (SHA:688363)

China flag China · Delayed Price · Currency is CNY
48.18
+0.63 (1.32%)
Apr 22, 2025, 10:45 AM CST
-10.06%
Market Cap 22.99B
Revenue (ttm) 5.37B
Net Income (ttm) 174.27M
Shares Out 478.36M
EPS (ttm) 0.36
PE Ratio 133.47
Forward PE 47.94
Dividend 0.11 (0.23%)
Ex-Dividend Date Aug 8, 2024
Volume 728,017
Average Volume 2,738,045
Open 48.02
Previous Close 47.55
Day's Range 47.55 - 48.44
52-Week Range 42.51 - 84.59
Beta 0.95
RSI 46.98
Earnings Date Apr 11, 2025

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th... [Read more]

Sector Materials
Founded 2000
Employees 4,444
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688363
Full Company Profile

Financial Performance

In 2024, SHA:688363's revenue was 5.37 billion, a decrease of -11.61% compared to the previous year's 6.08 billion. Earnings were 174.27 million, a decrease of -70.59%.

Financial Statements

News

There is no news available yet.